Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Miriam Holohan"'
Autor:
Sara Azhari Mohamed, Aoife Duffy, Veronica McInerney, Janusz Krawczyk, Amjad Hayat, Sean Naughton, Andrew Finnerty, Miriam Holohan, Aaron Liew, Muhammad Tubassam, Stewart Redmond Walsh, Timothy O'Brien, Linda Howard
Publikováno v:
Cytotherapy. 24:1259-1267
Approximately 1 in 3 patients with critical limb ischemia (CLI) are not suitable for surgical or endovascular revascularization. Those "no-option" patients are at high risk of amputation and death. Autologous bone marrow mesenchymal stromal cells (MS
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb529d18127dfc39d3819d98afabef17
https://doi.org/10.1016/j.jcyt.2022.07.002
https://doi.org/10.1016/j.jcyt.2022.07.002
Autor:
Veronica McInerney, Miriam Holohan, Sara Mohamed, Muhammad Tubassam, Tony Moloney, Sean Naughton, Amjad Hayat, Aaron Liew, Stewart R. Walsh, Janusz Krawczyk, Aoife Duffy, Andrew Finnerty, Linda Howard, Paul E. Burke, Eamon G. Kavanagh, Timothy O'Brien
Publikováno v:
Cytotherapy. 22(6)
Background Critical limb ischemia (CLI) is the most severe manifestation of peripheral vascular disease. Revascularization is the preferred therapy, but it is not achievable in 25%–40% of patients due to diffuse anatomic distribution of the disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44baf056f79d9ff33cd8b4d58bb6fe94
https://pubmed.ncbi.nlm.nih.gov/32273232
https://pubmed.ncbi.nlm.nih.gov/32273232